Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faith E Davies

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2017
Is molecular remission the goal of multiple myeloma therapy?Faith E Davies
Oncotarget|April 26, 2011
A stressful life (or death): combinatorial proteotoxic approaches to cancer-selective therapeutic vulnerabilityPaul Workman, Faith E Davies
The Lancet. Haematology|November 3, 2022
Maximising response depth is important in multiple myelomaXiaoyi Chen, Faith E Davies
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2022
Predicting the Future: Machine-Based Learning for MRD PrognosticationCharlotte Pawlyn, Faith E Davies
Blood|December 28, 2018
Toward personalized treatment in multiple myeloma based on molecular characteristicsCharlotte Pawlyn, Faith E Davies
Haematologica|May 15, 2012
DangER: protein ovERload. Targeting protein degradation to treat myelomaLauren I Aronson, Faith E Davies
Nature Reviews. Clinical Oncology|January 9, 2023
From little subclones grow mighty oaksEileen M Boyle, Faith E Davies
Haematologica|June 3, 2020
PIKing the next therapeutic target in multiple myelomaJessica L Caro, Faith E Davies
Blood|December 11, 2025
Improving MM outcomes with bispecific antibody combinationsFaith E Davies, Gareth J Morgan
Blood|December 18, 2025
Molecular modeling of Waldenström macroglobulinemiaGareth J Morgan, Faith E Davies
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
Hematology. American Society of Hematology. Education Program|December 10, 2017
Is molecular remission the goal of multiple myeloma therapy?Faith E Davies
Oncotarget|April 26, 2011
A stressful life (or death): combinatorial proteotoxic approaches to cancer-selective therapeutic vulnerabilityPaul Workman, Faith E Davies
The Lancet. Haematology|November 3, 2022
Maximising response depth is important in multiple myelomaXiaoyi Chen, Faith E Davies
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2022
Predicting the Future: Machine-Based Learning for MRD PrognosticationCharlotte Pawlyn, Faith E Davies
Blood|December 28, 2018
Toward personalized treatment in multiple myeloma based on molecular characteristicsCharlotte Pawlyn, Faith E Davies
Haematologica|May 15, 2012
DangER: protein ovERload. Targeting protein degradation to treat myelomaLauren I Aronson, Faith E Davies
Nature Reviews. Clinical Oncology|January 9, 2023
From little subclones grow mighty oaksEileen M Boyle, Faith E Davies
Haematologica|June 3, 2020
PIKing the next therapeutic target in multiple myelomaJessica L Caro, Faith E Davies
Blood|December 11, 2025
Improving MM outcomes with bispecific antibody combinationsFaith E Davies, Gareth J Morgan
Blood|December 18, 2025
Molecular modeling of Waldenström macroglobulinemiaGareth J Morgan, Faith E Davies
Pageof 25